Annelies H Boekhout1,2, Elizabeth Maunsell3,4, Gregory R Pond5,6, Jim A Julian5,6, Doug Coyle7, Mark N Levine5,6, Eva Grunfeld8,9. 1. Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada. a.boekhout@nki.nl. 2. Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. a.boekhout@nki.nl. 3. Center de Recherché du CHU de Québec, Québec, Québec, Canada. 4. Département de Médecine Sociale et Préventive, Université Laval, Québec, Québec, Canada. 5. Ontario Clinical Oncology Group, Hamilton, Ontario, Canada. 6. Department of Oncology, McMaster University, Hamilton, Ontario, Canada. 7. Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada. 8. Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada. 9. Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Abstract
PURPOSE: Prevailing wisdom suggests that implementation of a survivorship care plan (SCP) will address deficits in survivorship care planning and delivery for cancer patients. Here, we present 24-month results of a randomized clinical trial on health service and patient-reported outcomes among breast cancer patients transferred to their primary care physician for follow-up care. The 24-month assessments represent the long-term benefit and sustainability of the implantation of a SCP. METHODS: In all, 408 patients with early-stage breast cancer were randomized to the SCP or control group. Patient self-completed questionnaires, supplemented with telephone interviews, during the 24-month study period assessed health service and patient-reported outcomes. The primary outcome was cancer-specific distress. Secondary outcomes included health-related quality of life, patient satisfaction, continuity and coordination of care, and health service outcomes such as adherence to guidelines. RESULTS: Over the course of 24 months, there were no differences between both groups in health service and patient-reported outcomes. Women from Quebec compared to those from Western Canada (p < 0.001), women within 2 years of completion of primary treatment compared to a longer period (p = 0.013), and those with a higher SF-36 mental component score compared to a lower score (p = 0.044) were positively associated with adherence to guidelines. CONCLUSION: The implementation of a SCP in the transition of survivorship care from cancer center to primary care did not contribute to improved health service or patient-reported outcomes in this study population. Therefore, additional research is needed before widespread implementation of a SCP in clinical practice. IMPLICATIONS OF CANCER SURVIVORS: The transition of survivorship care from cancer center to the primary care setting showed no negative effect on health service and patient-reported outcomes.
PURPOSE: Prevailing wisdom suggests that implementation of a survivorship care plan (SCP) will address deficits in survivorship care planning and delivery for cancer patients. Here, we present 24-month results of a randomized clinical trial on health service and patient-reported outcomes among breast cancer patients transferred to their primary care physician for follow-up care. The 24-month assessments represent the long-term benefit and sustainability of the implantation of a SCP. METHODS: In all, 408 patients with early-stage breast cancer were randomized to the SCP or control group. Patient self-completed questionnaires, supplemented with telephone interviews, during the 24-month study period assessed health service and patient-reported outcomes. The primary outcome was cancer-specific distress. Secondary outcomes included health-related quality of life, patient satisfaction, continuity and coordination of care, and health service outcomes such as adherence to guidelines. RESULTS: Over the course of 24 months, there were no differences between both groups in health service and patient-reported outcomes. Women from Quebec compared to those from Western Canada (p < 0.001), women within 2 years of completion of primary treatment compared to a longer period (p = 0.013), and those with a higher SF-36 mental component score compared to a lower score (p = 0.044) were positively associated with adherence to guidelines. CONCLUSION: The implementation of a SCP in the transition of survivorship care from cancer center to primary care did not contribute to improved health service or patient-reported outcomes in this study population. Therefore, additional research is needed before widespread implementation of a SCP in clinical practice. IMPLICATIONS OF CANCER SURVIVORS: The transition of survivorship care from cancer center to the primary care setting showed no negative effect on health service and patient-reported outcomes.
Entities:
Keywords:
Breast cancer; Randomized clinical trial; Survivorship care plan
Authors: Prithwish De; Larry F Ellison; Ronald D Barr; Robert Semenciw; Loraine D Marrett; Hannah K Weir; Dagny Dryer; Eva Grunfeld Journal: CMAJ Date: 2011-02-22 Impact factor: 8.262
Authors: James L Khatcheressian; Patricia Hurley; Elissa Bantug; Laura J Esserman; Eva Grunfeld; Francine Halberg; Alexander Hantel; N Lynn Henry; Hyman B Muss; Thomas J Smith; Victor G Vogel; Antonio C Wolff; Mark R Somerfield; Nancy E Davidson Journal: J Clin Oncol Date: 2012-11-05 Impact factor: 44.544
Authors: Christine E Hill-Kayser; Carolyn C Vachani; Margaret K Hampshire; Gloria Di Lullo; Linda A Jacobs; James M Metz Journal: Cancer Date: 2013-08-06 Impact factor: 6.860
Authors: Brian L Sprague; Kim L Dittus; Claire M Pace; Dorothy Dulko; Lori A Pollack; Nikki A Hawkins; Berta M Geller Journal: Clin J Oncol Nurs Date: 2013-06 Impact factor: 1.027
Authors: E M L Verschuur; E W Steyerberg; H W Tilanus; S Polinder; M-L Essink-Bot; K T C Tran; A van der Gaast; L P S Stassen; E J Kuipers; P D Siersema Journal: Br J Cancer Date: 2008-12-09 Impact factor: 7.640
Authors: Denalee O'Malley; Shawna V Hudson; Larissa Nekhlyudov; Jenna Howard; Ellen Rubinstein; Heather S Lee; Linda S Overholser; Amy Shaw; Sarah Givens; Jay S Burton; Eva Grunfeld; Carly Parry; Benjamin F Crabtree Journal: J Cancer Surviv Date: 2016-06-08 Impact factor: 4.442
Authors: Sarah A Birken; Alecia S Clary; Shampa Bernstein; Jamiyla Bolton; Miriam Tardif-Douglin; Deborah K Mayer; Allison M Deal; Sara R Jacobs Journal: J Oncol Pract Date: 2018-07-13 Impact factor: 3.840
Authors: Sarah A Birken; Sarah Raskin; Yuqing Zhang; Gema Lane; Alexandra Zizzi; Mandi Pratt-Chapman Journal: J Cancer Educ Date: 2019-06 Impact factor: 2.037
Authors: Amye J Tevaarwerk; Jennifer R Klemp; Gijsberta J van Londen; Bradford W Hesse; Mary E Sesto Journal: Cancer Date: 2018-09-12 Impact factor: 6.860
Authors: Judith A Meiklejohn; Alexander Mimery; Jennifer H Martin; Ross Bailie; Gail Garvey; Euan T Walpole; Jon Adams; Daniel Williamson; Patricia C Valery Journal: J Cancer Surviv Date: 2016-05-02 Impact factor: 4.442